CARTREVIVE
LIVE

Serial Number

79365432

Owner

Hy2Care B.V.

Attorney

Bradley M. Stohry

Filing Date

Sep 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CARTREVIVE Trademark

Serial Number: 79365432 • Registration: 7369778

CARTREVIVE is a trademark filed by Hy2Care B.V. on September 14, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Hy2Care B.V. (3 trademarks)

Urmonderbaan 22

Entity Type: 26

Trademark Details

Filing Date

September 14, 2022

Registration Date

April 30, 2024

Published for Opposition

February 13, 2024

Goods & Services

Medical services, namely, cartilage repair in the human body; medical services, namely, pain management and inflammation reduction in the human body; medical services, namely, bone repair in the human body; dermatology services for the human body; dentistry services for the human body; surgical treatment services, namely, surgery of the human body; medical services for the diagnosis of conditions of the human body; drug screening of the human body for medical purposes; drug screening of the human body for medical purposes involving application of liquid polymers; drug screening of the human body for medical purposes involving application of hydrogels

Medical devices, namely, injection needles; medical devices, namely, syringes; medical devices for injection of liquid components in the human body, namely, injection needles; medical devices for injection of liquid polymers in the human body, namely, injection needles; medical devices for injection of hydrogels in the human body, namely, injection needles; medical devices for supply of pharmaceutical products for cartilage repair to the human body, namely, injection instruments with needles; medical devices for supply of pharmaceutical products for bone repair to the human body, namely, injection instruments with needles; medical devices for supply of dermal fillers to the human body; medical devices for supply of dental fillers to the human body, namely, injection needles; medical devices for supply of dental fillers to the human body, namely, syringes; medical devices for application of surgical glues and sealants to the human body; diagnostic apparatus for medical purposes, namely, ultrasound diagnostic apparatus; diagnostic apparatus for medical purposes, namely, X-ray diagnostic apparatus; cell culture instruments for medical use, namely, cell culture chambers

Pharmaceutical compositions for cartilage repair and treatments; pharmaceutical compositions for pain management and inflammation reduction; pharmaceutical compositions for bone repair; pharmaceutical gels for cartilage repair and treatments; pharmaceutical gels for pain management and inflammation reduction; pharmaceutical gels for bone repair; injectable pharmaceuticals for cartilage repair and treatments; injectable pharmaceuticals for pain management and inflammation reduction; injectable pharmaceuticals for bone repair; pharmaceutical products containing liquid polymers for cartilage repair and treatments; pharmaceutical products containing liquid polymers for pain management and inflammation reduction; pharmaceutical products containing liquid polymers for bone repair; pharmaceutical products containing hydrogels for cartilage repair and treatments; pharmaceutical products containing hydrogels for pain management and inflammation reduction; pharmaceutical products containing hydrogels for bone repair; advanced therapy medicinal products for cartilage repair and treatments; advanced therapy medicinal products for pain management and inflammation reduction; advanced therapy medicinal products for bone repair; advanced therapy medicinal products containing liquid polymers for cartilage repair and treatments; advanced therapy medicinal products containing liquid polymers for pain management and inflammation reduction; advanced therapy medicinal products containing liquid polymers for bone repair; advanced therapy medicinal products containing hydrogels for cartilage repair and treatments; advanced therapy medicinal products containing hydrogels for pain management and inflammation reduction; advanced therapy medicinal products containing hydrogels for bone repair; biological tissue cultures for medical purposes; medicated hydrogels for cartilage repair and treatments; medicated hydrogels for pain management and inflammation reduction; medicated hydrogels for bone repair; medicated hydrogels resorbable by the human body for cartilage repair and treatments; medicated hydrogels resorbable by the human body for pain management and inflammation reduction; medicated hydrogels resorbable by the human body for bone repair; pharmaceutical products for cartilage repair and treatments; pharmaceutical products for pain management and inflammation reduction; pharmaceutical products for bone repair; injectable dermal fillers; dental fillers, namely, teeth filling material; surgical glues and sealants

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Oct 24, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jun 6, 2025 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 21, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 21, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 21, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 21, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 21, 2025 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 17, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 29, 2024 FICS
FINAL DISPOSITION PROCESSED
Oct 28, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 30, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Feb 14, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 13, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 24, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 24, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 27, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 27, 2023 TROA
REFUSAL PROCESSED BY IB
Aug 2, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 13, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jul 13, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 8, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jun 7, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 5, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 24, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 20, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 16, 2023 REPR